Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Q Wu

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
Pharmacoeconomics|February 7, 2014
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in ChinaEric Q Wu, Jipan Xie, Chun Wu, et al.
Circulation|July 16, 2008
Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differencesJipan Xie, Eric Q Wu, Zhi-Jie Zheng, et al.
Journal of Medical Economics|May 28, 2010
Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasonsEric Q Wu, Rym Ben-Hamadi, Andrew P Yu, et al.
Clinical Therapeutics|June 27, 2015
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United StatesT Kim Le, Dendy Macaulay, Anupama Kalsekar, et al.
Journal of Medical Economics|May 20, 2009
Antidepressant treatment patterns and costs among US employeesHoward Birnbaum, Paul E Greenberg, Jackson Tang, et al.
Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.
Journal of Gastrointestinal Cancer|May 23, 2014
Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrence in gastrointestinal stromal tumor patients-a chart extract-based approachAnthony Paul Conley, Annie Guerin, Medha Sasane, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorderJames Signorovitch, M Haim Erder, Jipan Xie, et al.
Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.
Journal of Health Economics and Outcomes Research|August 18, 2022
Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United StatesEhab L Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, et al.
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Pharmacoeconomics|February 7, 2014
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in ChinaEric Q Wu, Jipan Xie, Chun Wu, et al.
Circulation|July 16, 2008
Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differencesJipan Xie, Eric Q Wu, Zhi-Jie Zheng, et al.
Journal of Medical Economics|May 28, 2010
Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasonsEric Q Wu, Rym Ben-Hamadi, Andrew P Yu, et al.
Clinical Therapeutics|June 27, 2015
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United StatesT Kim Le, Dendy Macaulay, Anupama Kalsekar, et al.
Journal of Medical Economics|May 20, 2009
Antidepressant treatment patterns and costs among US employeesHoward Birnbaum, Paul E Greenberg, Jackson Tang, et al.
Journal of Medical Economics|April 2, 2016
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysisNanxin Li, Yanni Hao, Valerie Koo, et al.
Journal of Gastrointestinal Cancer|May 23, 2014
Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrence in gastrointestinal stromal tumor patients-a chart extract-based approachAnthony Paul Conley, Annie Guerin, Medha Sasane, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorderJames Signorovitch, M Haim Erder, Jipan Xie, et al.
Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.
Journal of Health Economics and Outcomes Research|August 18, 2022
Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United StatesEhab L Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, et al.
Pageof 21